FLUME Funding
Funding history
FLUME’s development has been made possible by a combination of investment by the founders, together with two rounds of Angel/ Friends & Family investment as well as grant support; an MRC funded Elizabeth Blackwell ‘Proof of Concept’ award and an NIHR ‘Research for Patient Benefit’ award to fund first in human evaluations at Bristol.
2016-2019 Seed funding £450k
March 2020 Angel I £825k
March 2022 Angel II £2.1M
July 2024 Angel III £1.4M
looking ahead
We will consider the potential for further Angel funding around the end of 2024 and then anticipate raising a Series A round in H2 2025.